Evaluation of Hematological parameters as prognostic indicators in COVID -19 patients
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- These parameters are expected to act as indicators of immune status of patient, hyperinflammatory and cytokine storm status, indicators of superinfection , disease severity and extent of systemic inflammation
研究概览
简要总结
The study aims to assess the role of hematological parameters ,both direct and derived, in predicting the severity of COVID 19 patients.The parameters like absolute lymphocyte count,total leukocyte count,absolute neutrophil count, neutrophil lymphocyte ratio,platelet lymphocyte ratio,RDW to total platelet count ratio,mean platelet volume etc will be evaluated in predicting the severity of disease requiring early intervention in COVID 19 patients.These parameters will be correlated with other biochemical and clinical parameters also.
The results obtained in the study will be published in appropriate journals.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 1.00 Year(s) 至 80.00 Year(s)（—）
- 性别
- All
入选标准
- •ALL RT-PCR POSITIVE COVID-19 PATIENTS.
排除标准
- •All COVID unrelated cases .
- •Patients in which proper clinical details missing.
结局指标
主要结局
These parameters are expected to act as indicators of immune status of patient, hyperinflammatory and cytokine storm status, indicators of superinfection , disease severity and extent of systemic inflammation
时间窗: The parameters will be assessed at the time of admission and at the time of discharge in case of general ward patients and at 1 week interval in case of ICU patients
次要结局
- FEW DERIVED HEMATOLOGICAL PARAMETERS CAN ACT AS INDICTORS OF POOR PROGNOSIS IN COVID 19 PATIENTS(Parameters will be assessed at the time of discharge in general ward patients and at 1 week interval in ICU patients)